Skip to content
EmergingResearch compound

RAD‑150 (TLB‑150)

The benzoate ester of RAD-140. Not a single study exists on RAD-150 itself; all the evidence below concerns RAD-140 and describes myocarditis and heart failure.

Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

RAD-150 (TLB-150) vial

WHAT IS RAD-150 (TLB-150)?

Detailed overview

RAD-150 (TLB-150 benzoate) is not an independent compound in the pharmacological sense but the benzoate ester of RAD-140 (testolone). The ester is cleaved in the body and the real active agent is RAD-140. Shops market it as a longer-acting, more stable version. From this follows the most important sentence on this page: not a single published study exists on RAD-150 itself. Every paper cited below concerns RAD-140, and we say so deliberately, because elsewhere they are often sold as RAD-150 evidence. What is known about RAD-140 may apply to RAD-150 since it converts to the same molecule, but absorption, peak concentration and time course may differ, and nobody has measured that. The available human data on RAD-140 are not reassuring, and they are not efficacy data but harm case reports. Padappayil 2022 described acute myocarditis, the Schwartzman 2024 JACC case report myopericarditis, and Skorupski 2024 catastrophic heart failure linked to SARM abuse. These arose in young, otherwise healthy people. In animals the picture also contradicts the marketing: in Brown 2023, RAD-140 impaired skeletal muscle adaptation to exercise in female mice, worsened frailty status and raised mortality risk. That is precisely the opposite of what it is used for.

What it actually is

The benzoate ester of RAD-140 (testolone); cleaved to RAD-140 in the body.

Evidence of its own

None. No published study exists on RAD-150 itself.

Human data on RAD-140

Case reports of myocarditis, myopericarditis and heart failure in young users.

Animal finding

Brown 2023: impaired muscle adaptation and raised mortality risk in mice.

Legal status

Not a medicine. WADA-banned year-round (S1.2).

Data console

Lab data

/lab/molecular-data.jsonLIVE
> Androgenic:AnabolicRAD-140 has been described as muscle-selective relative to the prostate, but no reliable ratio based on human data is available, and for RAD-150 there are no data at all.
> AR bindingRAD-140 is a high-affinity non-steroidal androgen receptor …
> Active half-lifeismeretlen; a RAD-140 felezési ideje ~60 h
> Detection windowDoping laboratories screen for SARMs including RAD-140 and its metabolites by liquid chromatography-tandem mass spectrometry. To be avoided by tested athletes.
> AromatizationNO. RAD-140 and its ester are non-steroidal, are not substrates for aromatase and do not convert to estradiol.
> HepatotoxicityHIGH RISK. SARM-associated drug-induced liver injury is well documented within the class and applies to RAD-140. If used, regular liver enzyme monitoring is essential, but it bears emphasis that the most serious reported events with RAD-140 involved the heart rather than the liver.

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • Myocarditis and heart failure: several independent case reports describe acute myocarditis, myopericarditis and even catastrophic heart failure in young, otherwise healthy RAD-140 users.
  • Liver injury: SARM-associated drug-induced liver injury is well documented within the class and applies to RAD-140 as well.
  • HPTA suppression and lipid deterioration: endogenous testosterone production falls and HDL cholesterol declines.
  • An animal warning: in Brown 2023 RAD-140 IMPAIRED skeletal muscle adaptation in female mice, worsened frailty status and raised mortality risk. That is the opposite of what the compound is expected to do.

Contraindications · 4

  • Any known cardiac disease: the myocarditis and heart failure case reports linked to RAD-140 arose in young healthy people, which implies a worse outcome on an already diseased heart.
  • Existing liver disease or elevated baseline ALT/AST.
  • Pregnancy and breastfeeding: androgen receptor activation can cause fetal virilization, use is prohibited.
  • Competitive sport under testing: WADA bans SARMs year-round (S1.2) and screens for them routinely.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about RAD‑150 (TLB‑150)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.